Default options in advance directives: study protocol for a randomised clinical trial

Nicole B Gabler, Elizabeth Cooney, Dylan S Small, Andrea B Troxel, Robert M Arnold, Douglas B White, Derek C Angus, George Loewenstein, Kevin G Volpp, Cindy L Bryce, Scott D Halpern, Nicole B Gabler, Elizabeth Cooney, Dylan S Small, Andrea B Troxel, Robert M Arnold, Douglas B White, Derek C Angus, George Loewenstein, Kevin G Volpp, Cindy L Bryce, Scott D Halpern

Abstract

Introduction: Although most seriously ill Americans wish to avoid burdensome and aggressive care at the end of life, such care is often provided unless patients or family members specifically request otherwise. Advance directives (ADs) were created to provide opportunities to set limits on aggressive care near life's end. This study tests the hypothesis that redesigning ADs such that comfort-oriented care is provided as the default, rather than requiring patients to actively choose it, will promote better patient-centred outcomes.

Methods and analysis: This multicentre trial randomises seriously ill adults to receive 1 of 3 different ADs: (1) a traditional AD that requires patients to actively choose their goals of care or preferences for specific interventions (eg, feeding tube insertion) or otherwise have their care guided by their surrogates and the prevailing societal default toward aggressive care; (2) an AD that defaults to life-extending care and receipt of life-sustaining interventions, enabling patients to opt out from such care; or (3) an AD that defaults to comfort care, enabling patients to opt into life-extending care. We seek to enrol 270 patients who return complete, legally valid ADs so as to generate sufficient power to detect differences in the primary outcome of hospital-free days (days alive and not in an acute care facility). Secondary outcomes include hospital and intensive care unit admissions, costs of care, hospice usage, decision conflict and satisfaction, quality of life, concordance of preferences with care received and bereavement outcomes for surrogates of patients who die.

Ethics and dissemination: This study has been approved by the Institutional Review Boards at all trial centres, and is guided by a data safety and monitoring board and an ethics advisory board. Study results will be disseminated using methods that describe the results in ways that key stakeholders can best understand and implement.

Trial registration number: NCT02017548; Pre-results.

Keywords: Advance directive; Default option; Randomized clinical trial.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Study scheme. AD, advance directives; QOL, quality of life; RC, research coordinator.
Figure 2
Figure 2
Methods of inferring the causal effects of choices made in advance directives (ADs).

References

    1. Fields MJ, Cassel CK. Approaching death, improving care at the end of life. Washington DC: National Academy Press, 1997.
    1. Fried TR, Bradley EH, Towle VR et al. . Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002;346:1061–6. 10.1056/NEJMsa012528
    1. Facts on dying. 2001. .
    1. Angus DC, Barnato AE, Linde-Zwirble WT et al. , Robert Wood Johnson Foundation ICU End-Of-Life Peer Group. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med 2004;32:638–43. 10.1097/01.CCM.0000114816.62331.08
    1. Kwok AC, Semel ME, Lipsitz SR et al. . The intensity and variation of surgical care at the end of life: a retrospective cohort study. Lancet 2011;378:1408–13. 10.1016/S0140-6736(11)61268-3
    1. Smith AK, McCarthy E, Weber E et al. . Half of older Americans seen in emergency department in last month of life; most admitted to hospital, and many die there. Health Aff (Millwood) 2012;31:1277–85. 10.1377/hlthaff.2011.0922
    1. Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res 2010;45:565–76. 10.1111/j.1475-6773.2010.01082.x
    1. Wright AA, Keating NL, Balboni TA et al. . Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers’ mental health. J Clin Oncol 2010;28:4457–64. 10.1200/JCO.2009.26.3863
    1. Wright AA, Zhang B, Ray A et al. . Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008;300:1665–73. 10.1001/jama.300.14.1665
    1. Temel JS, Greer JA, Muzikansky A et al. . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733–42. 10.1056/NEJMoa1000678
    1. Bakitas M, Lyons KD, Hegel MT et al. . Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 2009;302:741–9. 10.1001/jama.2009.1198
    1. Connor SR, Pyenson B, Fitch K et al. . Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007;33:238–46. 10.1016/j.jpainsymman.2006.10.010
    1. Bakitas MA, Tosteson TD, Li Z et al. . Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 2015;33:1438–45. 10.1200/JCO.2014.58.6362
    1. Azoulay E, Pochard F, Kentish-Barnes N et al. . Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med 2005;171:987–94. 10.1164/rccm.200409-1295OC
    1. Detering KM, Hancock AD, Reade MC et al. . The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 2010;340:c1345 10.1136/bmj.c1345
    1. Wendler D, Rid A. Systematic review: the effect on surrogates of making treatment decisions for others. Ann Intern Med 2011;154:336–46. 10.7326/0003-4819-154-5-201103010-00008
    1. Siegel MD, Hayes E, Vanderwerker LC et al. . Psychiatric illness in the next of kin of patients who die in the intensive care unit. Crit Care Med 2008;36:1722–8. 10.1097/CCM.0b013e318174da72
    1. Silveira MJ, Kim SY, Langa KM. Advance directives and outcomes of surrogate decision making before death. N Engl J Med 2010;362:1211–18. 10.1056/NEJMsa0907901
    1. Degenholtz HB, Rhee Y, Arnold RM. Brief communication: the relationship between having a living will and dying in place. Ann Intern Med 2004;141:113–17. 10.7326/0003-4819-141-2-200407200-00009
    1. Nicholas LH, Langa KM, Iwashyna TJ et al. . Regional variation in the association between advance directives and end-of-life Medicare expenditures. JAMA 2011;306:1447–53. 10.1001/jama.2011.1410
    1. Teno JM, Gruneir A, Schwartz Z et al. . Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc 2007;55:189–94. 10.1111/j.1532-5415.2007.01045.x
    1. Fagerlin A, Schneider CE. Enough. The failure of the living will. Hastings Cent Rep 2004;34:30–42. 10.2307/3527683
    1. Kirschner KL. When written advance directives are not enough. Clin Geriatr Med 2005;21:193–209, x 10.1016/j.cger.2004.08.006
    1. Perkins HS. Controlling death: the false promise of advance directives. Ann Intern Med 2007;147:51–7. 10.7326/0003-4819-147-1-200707030-00008
    1. Tonelli MR. Pulling the plug on living wills. A critical analysis of advance directives. Chest 1996;110:816–22.
    1. Tulsky JA. Beyond advance directives: importance of communication skills at the end of life. JAMA 2005;294:359–65. 10.1001/jama.294.3.359
    1. Chapman GB, Li M, Colby H et al. . Opting in vs opting out of influenza vaccination. JAMA 2010;304:43–4. 10.1001/jama.2010.892
    1. Choi JJ, Laibson D, Madrian BC et al. . Defined contribution pensions: plan rules, participant decisions, and the path of least resistance. In: Poterba JM, ed.. Tax policy and the economy. Cambridge, MA: MIT Press, 2002:67–113.
    1. Horvat LD, Cuerden MS, Kim SJ et al. . Informing the debate: rates of kidney transplantation in nations with presumed consent. Ann Intern Med 2010;153:641–9. 10.7326/0003-4819-153-10-201011160-00006
    1. Johnson EJ, Goldstein D. Medicine. Do defaults save lives? Science 2003;302:1338–9. 10.1126/science.1091721
    1. Johnson EJ, Hershey JC, Meszaros J et al. . Framing, probability distortions, and insurance decisions. J Risk Uncertain 1993;7:35–51. 10.1007/BF01065313
    1. Madrian BC, Shea DF. The power of suggestion: Intertia in 401(k) participation and savings behavior. Q J Econ 2001;116:1149–87. 10.1162/003355301753265543
    1. Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. N Engl J Med 2007;357:1340–4. 10.1056/NEJMsb071595
    1. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA 2007;298:2415–17. 10.1001/jama.298.20.2415
    1. Quill CM, Halpern S. Deciphering the appropriateness of defaults: the need for domain-specific evidence. J Med Ethics 2012;38:721–2. 10.1136/medethics-2012-100724
    1. Hart J, Halpern SD. Default options in the ICU: widely used but insufficiently understood. Curr Opin Crit Care 2014;20:662–7. 10.1097/MCC.0000000000000146
    1. Halpern SD, Loewenstein G, Volpp KG et al. . Default options in advance directives influence how patients set goals for end-of-life care. Health Aff (Millwood) 2013;32:408–17. 10.1377/hlthaff.2012.0895
    1. Carstensen LL. The influence of a sense of time on human development. Science 2006;312:1913–15. 10.1126/science.1127488
    1. Carstensen LL, Isaacowitz DM, Charles ST. Taking time seriously. A theory of socioemotional selectivity. Am Psychol 1999;54:165–81. 10.1037/0003-066X.54.3.165
    1. Shea JA, Micco E, Dean LT et al. . Development of a revised Health Care System Distrust scale. J Gen Intern Med 2008;23:727–32. 10.1007/s11606-008-0575-3
    1. Harris PA, Taylor R, Thielke R et al. . Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.010
    1. 2007. Living Will and Healthcare Power of Attorney. .
    1. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995;274:1591–8.
    1. Barnato AE, Farrell MH, Chang CC et al. . Development and validation of hospital ‘end-of-life’ treatment intensity measures. Med Care 2009;47:1098–105. 10.1097/MLR.0b013e3181993191
    1. Miller FG, Gluck JP Jr, Wendler D. Debriefing and accountability in deceptive research. Kennedy Inst Ethics J 2008;18:235–51. 10.1353/ken.0.0196
    1. Heyland DK, Cook DJ, Rocker GM et al. . The development and validation of a novel questionnaire to measure patient and family satisfaction with end-of-life care: the Canadian Health Care Evaluation Project (CANHELP) Questionnaire. Palliat Med 2010;24:682–95. 10.1177/0269216310373168
    1. Heyland DK, Frank C, Tranmer J et al. . Satisfaction with end-of-life care: a longitudinal study of patients and their family caregivers in the last months of life. J Palliat Care 2009;25:245–56.
    1. Cohen SR, Mount BM, Bruera E et al. . Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med 1997;11:3–20. 10.1177/026921639701100102
    1. Cohen SR, Mount BM, Strobel MG et al. . The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995;9:207–19.
    1. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25–30. 10.1177/0272989X9501500105
    1. Zhang B, Nilsson ME, Prigerson HG. Factors important to patients’ quality of life at the end of life. Arch Intern Med 2012;172:1133–42. 10.1001/archinternmed.2012.2364
    1. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209–18. 10.1097/00006842-197905000-00004
    1. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med 2012;31:328–40. 10.1002/sim.4431
    1. Sommer A, Zeger SL. On estimating efficacy from clinical trials. Stat Med 1991;10:45–52. 10.1002/sim.4780100110
    1. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998;19:17–34. 10.1146/annurev.publhealth.19.1.17
    1. Angrist JD, Imbens GW, Rubin DW. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444–55. 10.1080/01621459.1996.10476902
    1. Cheng J, Small D. Bounds on causal effects in three-arm trials with noncompliance. J R Stat Soc 2006;68: 815–36. 10.1111/j.1467-9868.2006.00568.x
    1. Cheng J, Small D, Tan Z et al. . Efficient nonparametric estimation of causal effcts in randomized trials with noncompliance. Biometrika 2009;96:19–36. 10.1093/biomet/asn056
    1. Sussman JB, Hayward RA. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 2010;340:c2073 10.1136/bmj.c2073
    1. Baiocchi M, Cheng J, Small DS. Instrumental variable methods for causal inference. Stat Med 2014;33:2297–340. 10.1002/sim.6128
    1. Halpern SD, French B, Small DS et al. . Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med 2015;372:2108–17. 10.1056/NEJMoa1414293
    1. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics 2002;58:21–9. 10.1111/j.0006-341X.2002.00021.x
    1. Sudore RL, Fried TR. Redefining the ‘planning’ in advance care planning: preparing for end-of-life decision making. Ann Intern Med 2010;153:256–61. 10.7326/0003-4819-153-4-201008170-00008
    1. Localio AR, Berlin JA, Ten Have TR et al. . Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001;135:112–23. 10.7326/0003-4819-135-2-200107170-00012
    1. Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 2nd edn John Wiley & Sons, 2000.
    1. U.S. Department of Commerce Bureau of Economic Analysis. (accessed 16 Apr 2015).

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅